BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

ENABLEX Pages on BioPortfolio:

Biotechnology News ENABLEX Search
25 Aug 2009 ... Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/ENABLEX-news.htm...

BioPortfolio - Enablex
Enablex - BioPortfolio - Indepth. ... Press Releases About Enablex: BioPortfolio Logo. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) ...
http://www.bioportfolio.com/indepth/Enablex.html...

BioPortfolio.com - BioWeb VESICARE SOLIFENACIN SUCCINATE ...
Thanks in part to this, its sales will surge to $971m by 2011 while Enablex will reach $743m.- In the stress urinary incontinence sub-indication, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio Limited Urinary Incontinence Lifecycle management ...
Enablex's clinical trial program and study designs 70. Efficacy of Enablex 71. Side effects of Enablex 71. Yentreve (duloxetine) 71. Drug overview 71 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1052.html...

BioPortfolio's Approved Drugs News by Tradename - E
ENABLEX · ENALAPRIL_MALEATE · ENALAPRILAT ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

Urinary Incontinence Lifecycle management strategies retain ...
26 Dec 2007 ... At this point Detrol LA will be followed by the other second generation anticholinergics, GSK's Vesicare (solifenacin), Novartis' Enablex ...
http://www.bioportfolio.com/cgi-bin/acatalog/Urinary_Inconti...

BioPortfolio.com - BioWeb SUFENTA SUFENTANIL CITRATE Search
See Humira ™ (2913) D4E1 (Peptidyl MIM™) (1134) DAB389IL-2. See DN1924 - (2900) DAPD (Amdoxovir) (1668). See Enablex &. ...
http://www.bioportfolio.co.uk/SUFENTA+SUFENTANIL+CITRATE-bio...

Urinary Incontinence: Growing market offers commercial opportunity
Of the two drugs expected to launch in 2004, Vesicare is expected to prove more popular than Enablex, backed by favorable results from a head-to-head study ...
http://www.bioportfolio.com/news/datamonitor_49.htm...

New data published on KW-7158, a novel treatment of overactive bladder
29 Mar 2004 ... Vesicare is expected to prove more popular than Enablex, backed up by favorable results from a head-to-head study with Detrol. ...
http://www.bioportfolio.com/news/DailyUpdates_26.htm...

BioPortfolio - Healthcare Businesswomen's Association ...
Enablex Novartis Pharmaceuticals Corporation - Treatment for ... Enablex Novartis ... http://www.drugs.com/newdrugs/enablex-novartis-pharmaceutica. ...
http://www.bioportfolio.com/news/Healthcare_Businesswomen.pd...

Results from other life science and pharmaceutical sites:

ENABLEX®
ENABLEX is a once-a-day extended-release tablet and contains the following inactive ... After oral administration of ENABLEX to healthy volunteers, ...
http://www.pharma.us.novartis.com/product/pi/pdf/enablex.pdf...

ENABLEX | Industry information for ENABLEX
What was the percentage reduction in incontinence episodes at 2 years with ENABLEX® (darifenacin) in the open-label extension study? ...
http://www.medscape.com/infosite/enablex...

Enablex (darifenacin extended-release tablets) - Novartis ...
Information on the Novartis prescription medicine Enablex.
http://www.pharma.us.novartis.com/products/name/enablex.jsp...

Darifenacin - Wikipedia, the free encyclopedia
Darifenacin (Enablex, Emselex, Novartis) is a medication used to treat urinary ... Enablex product website, run by Novartis Pharmaceuticals Corporation ...
http://en.wikipedia.org/wiki/Darifenacin...

ENABLEX | Industry information for ENABLEX
Healthy volunteers on Detrol LA experienced a statistically significant increase in mean heart rate over 24 hours versus ENABLEX, while the change in mean ...
http://www.medscape.com/infosite/enablex/article-1...

DailyMed: About DailyMed
ENABLEX® (darifenacin) is an extended-release tablet which contains 7.5 mg or 15 mg ... ENABLEX is a once-a-day extended-release tablet and contains the ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7869...

ENABLEX | Industry information for ENABLEX
79% median reduction in incontinence episodes leading to a change in pads or clothing with ENABLEX 15 mg, regardless of severity (vs 55% with placebo)1* ...
http://www.medscape.com/infosite/enablex/article-4...

Enablex (darifenacin) Extended-Release Tablets
11 Jul 2009 ... Enablex (darifenacin) Extended-Release Tablets. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

ENABLEX | Industry information for ENABLEX
ENABLEX is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ...
http://www.medscape.com/infosite/enablex/article-2...

Enablex (darifenacin hydrobromide) Extended-Release Tablets ...
Enablex (darifenacin hydrobromide) Extended-Release Tablets December 2008. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug
Evaluation ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.